During the COVID-19 pandemic hitting the world and the United States in full force, several national funding opportunities have been issued. These are listed below.
- Federal Agency Grant and Funding Opportunities related to the COVID-19 Outbreak
- HHS COVID-19 Funding announcements as of 8-10-20.
- Additional funding opportunities are provided below.
| National Institute of Neurological Disorders and Stroke (NINDS) | Notice of Special Interest regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for the Establishment and Maintenance of a Research Database for Neurological Manifestations of the SARS-CoV-2 | Budget varies | Applications accepted on a rolling basis from April 6, 2020 until May 9, 2020 |
| Department of Energy (DOE) | Invitation for COVID-19 scientific questions
|
DOE Resources | Rolling |
| National Institutes of Health (NIH) NIAID | Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed)
|
$4,050,000
Budget varies |
6/29/2020
Rolling |
| National Institutes of Health (NIH) NIAID, NIA | Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) | Not limited | 5/13/2020; 9/13/2020; and others |
| National Institutes of Health (NIH) NCI, NCCIH, NHGRI, NIAID, NICHD, NIDDK, NIEHS, NIGMS, NIMHD, NIBIB | Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional) | Not limited | See Emergency Notice of Special Interest by IC |
| National Institutes of Health (NIH) NIEHS | NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) – NOT-ES-20-020
NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed) – NOT-ES-20-017
Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral/Social Sciences – NOT-OD-20-097 |
Expires: May 04, 2021 PA-18-935 Urgent Supplement – (Clinical Trial Optional) PA-18-591 Supplements to Existing NIH Grants (Clinical Trial Optional); 1 year support for supplements/competitive revisionsRFA-ES-19-011 Time-Sensitive Research in Environ. Health Sciences (R21 No Clinical Trials); Max 2yrs. Expires: April 25, 2020Requests for activities to be completed by the end of the current grant period or no-cost extension; Max $200,000; only existing NIEHS WTP awardees eligible. – NOT-ES-20-017Expires: April 01, 2021 Max two yrs; $100,000 direct costs/yr.; applications accepted on a rolling basis. – NOT-OD-20-097 |
NIH Grants and Funding guidance |
| National Institutes of Health (NIH) NIAID, NIGMS | Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV) | Not limited | 2/6/2021 (rolling basis) |
| National Institutes of Health (NIH) NIAID | Administrative Supplement | Not limited | 2/6/2021 (rolling basis) |
| National Institutes of Health (NIH) NIDA | Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus | $100K direct costs/yr | 3/31/2021 (rolling basis) |
| National Institutes of Health (NIH) NHLBI | Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) | Not limited | 10/5/2020 (rolling basis) |
| National Science Foundation (NSF) | RAPID: Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) | $200,000 | Check with program officers |
| Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19) | $200,000 (RAPID) & supplemental funding requests | Check with program officers | |
| Biomedical Advanced Research and Development Authority (BARDA) | Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) | Negotiated after white paper stage | 10/31/2020 |
| National Center for Advancing Translational Sciences (NCATS) | Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus – NOT-TR-20-016 | Budgets limited to less than 25% current parent award | Expires – 1/26/2022 |